7 reports

NO has a solid place in asthma management.

  • Antiseptics
  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • ALCOHOL ADDICTION - PIPELINE BY MONTISERA LTD, H1 2018
  • ALCOHOL ADDICTION - PIPELINE BY KYORIN PHARMACEUTICAL CO LTD, H1 2018

Brar participated in development efforts for asthma and topical Aristocort.

  • Antiseptics
  • Therapy
  • United States
  • Product Initiative
  • MediciNova, Inc.
  • ALCOHOL ADDICTION - PIPELINE BY KYORIN PHARMACEUTICAL CO LTD
  • ALCOHOL ADDICTION - PIPELINE BY LOHOCLA RESEARCH CORP

Brar participated in development efforts for asthma and topical Aristocort.

  • Antiseptics
  • Drug Test
  • United States
  • Product Initiative
  • Omeros Corporation
  • ALCOHOL ADDICTION - PIPELINE BY KYORIN PHARMACEUTICAL CO LTD, H2 2017
  • ALCOHOL ADDICTION - PIPELINE BY KINNOV THERAPEUTICS SAS, H2 2017

Brar participated in development efforts for asthma and topical Aristocort.

  • Antiseptics
  • Therapy
  • United States
  • Product Initiative
  • MediciNova, Inc.

The prominent features of this report are - ##.

  • Antiseptics
  • Clinical Trial
  • Mouth Disease
  • OTC
  • Therapy

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Antiseptics
  • Clinical Trial
  • Therapy
  • World
  • GlaxoSmithKline plc

About MN-## (ibudilast) MN-## (ibudilast) has been marketed in Japan and Korea since 1989 to treat post-stroke complications and bronchial asthma.

  • Antiseptics
  • Therapy
  • United States
  • World
  • Alkermes plc